Physician profile
Jeffrey E Mccall
NPI 1356569305
$1,976.47
in general payments reported to CMS, 2019-2025
14 companies · $279 in 2025
The $279 reported for 2025 was more than what 93% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.58 · 2022: $219 · 2023: $1,095 · 2024: $318 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.03 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $473.73 | 2023-2024 | Hemosphere |
| Silk Road Medical, INC. | $319.74 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Becton, Dickinson and Company | $245.84 | 2024-2025 | Hemosphere |
| Medical Device Business Services, INC. | $226.53 | 2023 | Ethicon |
| Merck Sharp & Dohme LLC | $204.92 | 2022-2025 | Bridion |
| Veryan Medical Incorporated | $148.22 | 2022-2023 | Biomimics 3d Vascular Stent System |
| Shockwave Medical, INC | $129.13 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $86.76 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Bard Peripheral Vascular, INC. | $49.54 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.70 | 2025 | Xifaxan |
| Janssen Biotech, INC. | $22.58 | 2024 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $18.03 | 2025 | Entyvio |
| Intercept Pharmaceuticals, INC. | $16.04 | 2021 | |
| Acacia Pharma INC | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.